The present analysis, which involved a total of 50 case-control studies with 35,915 CHD patients and 48,873 control subjects, is by far the most comprehensive analysis evaluating the relationship between CDKN2B-AS1 variants rs1333049 and rs4977574 and the risk of CHD. The gene discussed is CDKN2B; the disease is coronary artery disorder.